×

BioNexus Gene Lab EBITDA Margin 2019-2024 | BGLC

Current and historical EBITDA (Earnings Before Interest, Taxes, Depreciation and Amortization) margin for BioNexus Gene Lab (BGLC) over the last 10 years. The current EBITDA margin for BioNexus Gene Lab as of September 30, 2024 is .
BioNexus Gene Lab EBITDA Margin Historical Data
Date TTM Revenue TTM EBITDA EBITDA Margin
2024-09-30 $0.01B $-0.00B -11.11%
2024-06-30 $0.01B $-0.00B -22.22%
2024-03-31 $0.01B $-0.00B -20.00%
2023-12-31 $0.01B $-0.00B -20.00%
2023-09-30 $0.01B $-0.00B -18.18%
2023-06-30 $0.01B 0 0.00%
2023-03-31 $0.01B 0 0.00%
2022-12-31 $0.01B 0 0.00%
2022-09-30 $0.01B 0 0.00%
2022-06-30 $0.01B 0 0.00%
2022-03-31 $0.01B 0 0.00%
2021-12-31 $0.01B 0 0.00%
2021-09-30 $0.01B 0 0.00%
2021-06-30 $0.01B 0 0.00%
2021-03-31 $0.01B 0 0.00%
2020-12-31 $0.01B $0.00B 9.09%
2020-09-30 $0.01B $0.00B 14.29%
2020-06-30 $0.00B $0.00B 25.00%
2020-03-31 $0.00B $0.00B 33.33%
2019-12-31 $0.00B 0 nan%
2019-09-30 $0.00B 0 nan%
2019-06-30 $0.00B 0 nan%
2019-03-31 $0.00B 0 nan%
Sector Industry Market Cap Revenue
Medical Medical Services $0.007B $0.010B
BioNexus Gene Lab Corp. is an emerging company in the business of selling chemical raw materials principally in the Southeast Asia region and the development of biopsy tests for early diagnosis and personalized health management. BioNexus Gene Lab Corp. is based in KUALA LUMPUR, Malaysia.
Stock Name Country Market Cap PE Ratio
Elevance Health (ELV) United States $84.844B 10.53
Cencora (COR) United States $43.438B 16.33
DiDi Global (DIDIY) China $22.990B 0.00
Natera (NTRA) United States $21.203B 0.00
ICON (ICLR) Ireland $17.541B 15.62
Viatris (VTRS) United States $14.824B 4.57
Avantor (AVTR) United States $14.429B 21.63
Revvity (RVTY) United States $13.631B 23.68
BioMerieux (BMXMF) France $12.250B 0.00
CochLear (CHEOY) Australia $11.924B 0.00
Solventum (SOLV) United States $11.390B 0.00
Medpace Holdings (MEDP) United States $10.405B 29.31
Doximity (DOCS) United States $9.999B 58.86
Charles River Laboratories (CRL) United States $9.340B 18.05
HealthEquity (HQY) United States $8.390B 42.09
Sonic Healthcare (SKHHY) Australia $8.095B 0.00
Bausch + Lomb (BLCO) Canada $6.339B 29.51
Amplifon S.p.A (AMFPF) Italy $5.864B 29.89
Sotera Health (SHC) United States $3.858B 20.64
Organon (OGN) United States $3.853B 3.89
BrightSpring Health Services (BTSG) United States $3.018B 64.18
Surgery Partners (SGRY) United States $2.706B 30.85
Concentras Parent (CON) United States $2.456B 0.00
Ardent Health Partners (ARDT) United States $2.405B 0.00
Alignment Healthcare (ALHC) United States $2.216B 0.00
GeneDx Holdings (WGS) United States $2.188B 0.00
Premier (PINC) United States $2.054B 10.69
PACS (PACS) United States $1.971B 0.00
GoodRx Holdings (GDRX) United States $1.738B 45.60
Ryman Healthcare (RYHTY) New Zealand $1.720B 0.00
Teladoc Health (TDOC) United States $1.639B 0.00
Progyny (PGNY) United States $1.510B 30.57
Establishment Labs Holdings (ESTA) $1.268B 0.00
Embecta (EMBC) United States $1.177B 8.23
CareDx (CDNA) United States $1.154B 0.00
Pediatrix Medical (MD) United States $1.119B 10.95
AMN Healthcare Services Inc (AMN) United States $0.935B 6.33
Agilon Health (AGL) United States $0.791B 0.00
SBC Medicals (SBC) United States $0.572B 0.00
QDM (QDMI) Hong Kong, SAR China $0.566B 14.81
InnovAge Holding (INNV) United States $0.534B 0.00
Auna S.A (AUNA) Luxembourg $0.516B 0.00
DocGo (DCGO) United States $0.438B 16.50
Sonida Senior Living (SNDA) United States $0.436B 0.00
Enhabit (EHAB) United States $0.390B 33.70
COMPASS Pathways (CMPS) United Kingdom $0.284B 0.00
Sera Prognostics (SERA) United States $0.281B 0.00
Performant Healthcare (PHLT) United States $0.237B 0.00
LifeMD (LFMD) United States $0.227B 0.00
Biodesix (BDSX) United States $0.215B 0.00
MultiPlan (MPLN) United States $0.209B 0.00
Beauty Health (SKIN) United States $0.200B 0.00
Nutex Health (NUTX) United States $0.189B 0.00
ModivCare (MODV) United States $0.177B 9.60
So-Young (SY) China $0.097B 16.41
Ascend Wellness Holdings (AAWH) United States $0.093B 0.00
IceCure Medical (ICCM) Israel $0.068B 0.00
NeueHealth (NEUE) United States $0.061B 1.61
Singular Genomics Systems (OMIC) United States $0.049B 0.00
OncoCyte (OCX) United States $0.039B 0.00
Pheton Holdings (PTHL) China $0.027B 0.00
NeuroOne Medical Technologies (NMTC) United States $0.025B 0.00
Co-Diagnostics (CODX) United States $0.023B 0.00
Oncology Institute (TOI) United States $0.022B 0.00
SeaStar Medical Holding (ICU) United States $0.009B 0.00
KindlyMD (KDLY) United States $0.008B 0.00
XWELL (XWEL) United States $0.008B 0.00
Intelligent Bio Solutions (INBS) United States $0.006B 0.00
NewGenIvf Group (NIVF) Thailand $0.004B 0.00
ISpecimen (ISPC) United States $0.003B 0.00
Aclarion (ACON) United States $0.001B 0.00
Cano Health (CANOQ) United States $0.000B 0.00